UltraThera Technologies, Inc.

UltraThera Technologies, Inc. manufactures and markets the GyroStim. The company has its headquarters in Colorado Springs, CO, and has manufacturing located in Golden, CO. 

​

Since its founding in 2007, UltraThera has had a passionate determination to fulfill the tremendous unmet clinical need for a safe and effective therapeutic device for treatment of vestibular dysfunction that can result from concussion, TBI, congenital conditions such as cerebral palsy, illness such as COVID, pharmaceutical side effects, chemo therapy, and numerous neurological conditions.

 

On August 10th, 2021, UltraThera received the FDA's determination that GyroStim is officially designated as a Breakthrough Medical Device. This prestigious recognition was followed by the FDA's decision on April 27, 2022, to allow UltraThera to market GyroStim as a medical device.

 

These accomplishments are the culmination of tremendous determination, dedication, and effort at UltraThera, however, our journey continues. GyroStim, and its vast clinical potential, is at the center of a multi-site clinical effort to collect prospective clinical data that will allow UltraThera to expand GyroStim's clinical reach and marketing power into additional clinical markets in desperate need of an effective solution.

​

Today, there are over 50 systems in the U.S. and eight other countries. Most systems are available for public use at neuro-rehab and physical therapy clinics. Other installations have been placed at universities, research labs, and military installations, including the Mayo Clinic AMVRL Lab, Life University, Parker University, the U.S. Air Force Academy's Human Performance Lab, the Smead Aerospace Engineering Sciences University of Colorado at Boulder, Brazilian Air Force, German Air Force, and AC Milan Soccer Team MilanLab sports science center.

 

GyroStim is protected by multiple patents, trademarks, and copyrights.

​

​To learn more or to schedule an interview with CEO Kevin Maher, please call 719-685-7883x101 or e-mail inquiries@gyrostim.com.

​